Global Single-Use Bioreactors Market – Industry Trends and Forecast to 2030

Single-Use Bioreactors Market Analysis and Size

The growing acceptance of single-use bioreactors amongst small companies and start-ups, decreased automation complications, ease in the cultivation of marine organisms, lessened energy and water ingestion, the increasing pf biologics market, technological developments in single-use bioreactors, and the growing biopharmaceutical research and development are reasons propelling the growth of the global single-use bioreactors market.

Data Bridge Market Research analyses that the global single-use bioreactors market which was USD 5.79 billion in 2022, is expected to reach USD 12.82 billion by 2030, and is expected to undergo a CAGR of 16.05% during the forecast period 2023-2030. This indicates that the market value. “Single-use Bioreactors System” dominates the product segment of the global single-use bioreactors market owing to rowing acceptance of single-use bioreactors amongst small companies and start-ups worldwide. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Single-Use Bioreactors Market Scope and Segmentation

Market Definition

Single-use bioreactors are altogether favorable for the production of biopharmaceutical goods because of their high operation. They have turned out to be greatly advanced these days due to endless efforts by companies to spread goods. They are seen performing on improvising sensor systems, designs, stirring mechanisms, and film technology of single-use bioreactors.         

Global Single-Use Bioreactors Market Dynamics

Drivers

• Cost-Efficiency

Single-use bioreactors significantly reduce capital investment and operational costs compared to traditional stainless steel bioreactors. This cost-efficiency is a major driver, especially for smaller biotech companies and contract manufacturing organizations (CMOs).

• Rapid Bio manufacturing

Single-use bioreactors allow for faster start-up times, increased production flexibility, and quicker batch turnaround. This is critical for producing biopharmaceuticals, vaccines, and cell therapies with shorter production timelines.

• Reduced Cross-Contamination Risk

The single-use design minimizes the risk of cross-contamination between batches, ensuring product safety and quality, and eliminating the need for costly and time-consuming cleaning and validation procedures.

Opportunities

• Emerging Markets

Growing pharmaceutical and biotechnology sectors in emerging markets, such as Asia-Pacific and Latin America, present significant opportunities for single-use bioreactor manufacturers.

• Technological Advancements

Continuous technological advancements, such as improved sensors, control systems, and single-use materials, create opportunities for enhanced performance and reliability.

Restraints/ Challenges

• Regulatory Compliance

Ensuring regulatory compliance, especially for critical processes, can be challenging due to evolving guidelines and standards related to single-use technologies.

• Limited Volume Handling

Single-use bioreactors may have limitations in handling larger production volumes, which could be a constraint for companies producing blockbuster biopharmaceuticals.

• Environmental Concerns

The disposal of single-use bioreactor components can raise environmental concerns, and biopharmaceutical companies may face scrutiny regarding their environmental impact.

 This global single-use bioreactors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global single-use bioreactors market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Recent Development

• In November 2022, Sartorius GA (Germany) planned to invest in growing its operations by establishing new R&D laboratories and digitalizing & automating equipment, among other approaches. This development was aimed at meeting the high demand from the biopharmaceutical industry

Global Single-Use Bioreactors Market Scope

Global single-use bioreactors market is segmented on the basis of product, type, type of molecule, cell type, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Product

• Single-use Bioreactors System
• Single-use Media Bag
• Single-use Filtration Assemblies

Type

• Stirred Tank Single-use Bioreactors
• Bubble Column Single-use Bioreactors
• Wave Induced Single-use Bioreactors

Type of Molecule

• Monoclonal Antibodies (MABs)
• Vaccine, Stem Cells
• Gene–Modified Cells
• Other Molecules

Cell Type

• Mammalian Cells
• Bacteria Cells
• Yeast Cells
• Other Cells

Application

• Research and Development
• Process Development
• Bio production

End User

• Pharmaceutical and Biopharmaceutical Companies
• Academic and Research Institutes
• Contract Research Organizations (CROs)
• Contract Manufacturing Organizations (CMOs)

Global Single-Use Bioreactors Market Regional Analysis/Insights

The global single-use bioreactors market is analysed and market size insights and trends are provided by country, product, type, type of molecule, cell type, application and end user as referenced above.     

The countries covered in the global single-use bioreactors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global single-use bioreactors market because of factors such as the existence of a developed biopharmaceutical industry and the existence of major manufacturers performing in the global single-use bioreactors market are one of the major factors further boosting the growth of the global single-use bioreactors market in the region  

Asia-Pacific is expected to show a rapid and lucrative growth rate in the forecast period of 2023 to 2030 owing to the increasing of the biopharmaceutical industry, growth of life science research, escalating investments by pharmaceutical and biotechnology companies, and the increasing number of CROs and CMOs in the various emerging economies are the factors further to aid in the growth of the global single-use bioreactors market in the region during the forecast period 2023-2030.

The country section of the global single-use bioreactors market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data. The global single-use bioreactors market is analysed and market size insights and trends are provided by country, product, indication and end user as referenced above.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global single-use bioreactors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global single-use bioreactors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on global single-use bioreactors market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Single-Use Bioreactors Market Share Analysis

The global single-use bioreactors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global single-use bioreactors market.

Some of the major players operating in the global single-use bioreactors market are:

• Merck KGaA (Germany)
• CESCO BIOENGINEERING CO., LTD. (South Korea)
• GENERAL ELECTRIC (U.S.)
• Solida Biotechnology GmbH (Germany)
• Applikon Biotechnology (Netherlands)
• Danaher (U.S.), Celltainer (Netherlands)
• Pierre Guérin (France)
• Cellexus Ltd (U.K.)
• Esco Micro Pte Ltd. (Singapore)
• Thermo Fisher Scientific (U.S.)
• Sartorius AG (Germany)
• Eppendorf AG (Germany)
• Distek, Inc. (U.S.)
• PBS Biotech, Inc. (U.S.)
•  PARKER HANNIFIN CORP (U.S.)
• ABEC (U.S.)
• DCI-Biolafitte (France)

SKU-34964